September 21, 2014     Japanese 
  JCN 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
 
Share:
Fujitsu, Zoegene Launch Joint Project for Drug Discovery
 

Tokyo, Apr 25, 2005 (JCN) - Zoegene and Fujitsu (TSE: 6702) announced on April 21 that they have launched a joint project for developing innovative agents.

Under this partnership, the two companies will strive to discover hit compounds by leveraging their unique strengths: ZOEGENE's expertise in protein expression, crystal analysis and compound synthesis, and Fujitsu's proprietary drug discovery technology de novo SBDD.

Specifically, they aim to identify a compound that inhibits BACE-1, a beta-secretase enzyme that are considered to be a causing factor of Alzheimer's disease.

The two companies expect that this project will contribute to the development of innovative drugs for intractable diseases.

By Aki Tsukioka Contributor

Copyright © 2014 JCN. All rights reserved. A division of Japan Corporate News Network KK.


 Company Profile |   Print  |   Alerts
ACN Newswire

 Recent  Fujitsu Limited News  
  Kyushu University and Fujitsu Establish Joint Research Unit on Mathematical Techniques for Use in Social System Design  (Sept 12, 2014)
  Fujitsu Laboratories Develops World's First Software to Automate Production-Line Image Recognition  (Sept 10, 2014)
  Fujitsu, NTT, and NEC Move Forward on Commercialization of World's Top-Level, 400Gbps-class Optical Transmission Technology  (Sept 4, 2014)
  Fujitsu Computer System to Process Observational Data for JAXA's GPM/DPR Mission to Measure Global Precipitation  (Sept 2, 2014)
  Fujitsu Group to Carry out Joint Disaster Response Drills  (Aug 28, 2014)
  Fujitsu Introduces the ETERNUS TR Series of Storage Designed for Large-Scale Virtualization Environments  (Aug 27, 2014)
  Fujitsu Enhances Big Data Analytics Solution to Facilitate Decision-Making on the Front Lines of Business  (Aug 14, 2014)
  Fujitsu System for Management of Collections Information Now Operating at Chosun Minhwa Museum  (Aug 13, 2014)
  University of Tokyo's RCAST, Fujitsu, and Kowa Successfully Generate a Novel Active Compound Targeting Cancer Using IT-based Drug Discovery Technology  (Aug 7, 2014)
  Fujitsu Offers FENICS II Business Wi-Fi Service to Promote Business Use of Smart Devices  (Aug 6, 2014)


 
CSR Report Download
Annual Reports

  More >>    
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)